Our portfolio

NAIS and Evergreen are two regional industrial cleaning companies, acquired simultaneously, to create a national industrial cleaning platform that offers a one stop shop solution to its customers with best-in-class service quality. The combined entity serves a wide range of end markets including refining, petrochemical, power generation, manufacturing, mining and waste-to-energy. It provides base cleaning services as well as specialty services.

WIRB is the largest US « IRBs » (Institutional Review Boards), which are federally mandated to approve ethical issues in research protocols involving human subjects.

Ionisos is a specialist in ionising radiation sterilisation and was created through the 1993 merger of Conservatome and Amphytrion. Ionisos is the leading cold sterilisation service provider in France and Spain. It is the only group in France that provides all three cold sterilisation technologies: gamma radiation, beta radiation and ethylene oxide. The company employs about one hundred staff across its seven sites in France and Spain.

Envision Pharma is an international, innovative global technology and scientific communication company serving pharmaceutical, biotechnology, and medical device companies. Envision currently provides service and product solutions to more than 75 client companies, including 18 of the top 20 pharmaceutical companies. Envision currently has ten offices, three in the United Kingdom, five in the United States, two in Asia Pacific, and employs around 450 team members.

Mirion-Canberra group is a global provider of radiation detection, measurement, analysis and monitoring products to the nuclear, home security & defence, and medical markets. The group derives most of its revenues from segments where it holds global #1 market positions: radiation monitoring systems, radiochemistry and health physics. It operates 18 industrial sites and employs ~ 2,000 people.

Claritev (ex MultiPlan) is the industry’s most comprehensive provider of healthcare cost management solutions in the U.S. With a network of over one million healthcare providers with extensive proprietary analytics, Claritev generates over $11 billion in medial cost savings on about 40 million claims annually, acting as an intermediary on behalf of those paying for healthcare. In exchange, healthcare providers benefit from directed patient flow and a single point of payment.